Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma

• Status: Completed
• Trial end date: 2010-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the role of versican and hyaluronan measurements in induced sputum as biomarkers of asthma. Enroll 10 subjects with mild persistent asthma who are not receiving treatment with a controller therapy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Associated Scientists to Help Minimize Allergies
• Collaborators: Benaroya Research Institute; GlaxoSmithKline
• Treatments: Fluticasone; Hyaluronic Acid; Xhance

Criteria

Inclusion Criteria:

• Allergic asthma defined as a positive methacholine challenge

Exclusion Criteria:

• Non-atopic patients